PHASE 3 TRIAL RESULTS: EFFICACY AND SAFETY OF ELAGOLIX IN A SUBSET OF WOMEN WITH UTERINE FIBROIDS AND ADENOMYOSIS. Meeting Abstract

sustainable development goals

publication date

  • September 1, 2019

webpage

published in

start page

  • E4

end page

  • E4

volume

  • 112

issue

  • 3